| View |
|
DRP-6113-07
|
Cefuroxime (as axetil)
|
Temlex
|
500 mg
|
Film-Coated Tablet
|
Antibacterial (Cephalosporin)
|
Sance Laboratories Pvt. Ltd
|
India
|
-
|
04 February 2022
|
12 March 2025
|
| View |
|
DRP-5411
|
Fluticasone Propionate
|
Flutiright
|
500 mcg/mL (0.05% w/v) 50 mcg per actuation
|
Suspension for Nasal Spray
|
Corticosteroid
|
Norris Medicines Limited
|
India
|
Renewal
|
07 April 2024
|
01 August 2029
|
| View |
|
DRP-6275-02
|
Co-Amoxiclav
|
Xovax
|
625mg
|
Film-Coated Tablet
|
Antibacterial (Combination of penicillin and beta lactamase inhibitor)
|
UniMedicolabs
|
India
|
Automatic Renewal
|
24 May 2023
|
05 June 2028
|
| View |
|
DRP-073-11
|
CEFACLOR (AS MONOHYDRATE)
|
FACLOR
|
250 mg/5 mL
|
Granules for Suspension
|
ANTIBACATERIAL (CEPHALOSPORIN)
|
J.M. TOLMANN LABORATORIES INC.
|
Philippines
|
Renewal
|
08 May 2024
|
09 July 2029
|
| View |
|
DRP-2983-09
|
Felodipine
|
Unbranded
|
5 mg
|
Extended Release Tablet
|
Calcium Channel Blocker
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
17 January 2024
|
18 May 2029
|
| View |
|
DRP-3916-02
|
Candesartan Cilexetil
|
Candego-16
|
16 mg
|
Tablet
|
Angiotensin II Antagonist
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
25 August 2022
|
14 August 2027
|
| View |
|
DRP-4936-02
|
Ketorolac Trometamol
|
Ketroxen
|
30mg/mL
|
Solution for Injection (IM/IV)
|
Non-Opioid Analgesic
|
Nitin Lifesciences Ltd.
|
India
|
Renewal
|
25 August 2022
|
13 September 2028
|
| View |
|
DRP-6810-09
|
Co-Amoxiclav
|
HI-CLAV
|
625 mg
|
Film-Coated Tablet
|
Antibacterial (Penicillin-Beta-Lactamase Inhibitor Combination)
|
UNI MEDICOLABS
|
India
|
CLIDP Conversion
|
25 August 2022
|
26 August 2026
|
| View |
|
DRP-7944-10
|
Amlodipine (as besilate) + Losartan Potassium
|
Amlozan
|
5 mg/ 50 mg
|
Film-Coated Tablet
|
Calcium Channel Blocker (Dihydropyridine derivative) + Angiotensin II Receptor Blocker
|
Healthcare Pharmaceuticals Ltd.
|
Bangladesh
|
CLIDP Conversion
|
25 August 2022
|
16 October 2025
|
| View |
|
DRP-8994-08
|
Gliclazide
|
Gliclaphil
|
60 mg
|
Modified Release Tablet
|
Blood Glucose Lowering Drug (Sulfonylurea)
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
02 November 2024
|
14 August 2030
|
| View |
|
DRP-9078-06
|
Sitagliptin (as phosphate)
|
Sitaphil
|
50 mg
|
Film-Coated Tablet
|
Dipeptidyl Peptidase 4 (DPP-4) Inhibitor
|
Stallion Laboratories Pvt. Ltd.
|
India
|
CLIDP Conversion
|
25 August 2022
|
31 October 2025
|
| View |
|
DRP-9350-06
|
Salbutamol (as sulfate)
|
None
|
100 mcg per actuation
|
Suspension Metered Dose Inhaler
|
Selective Beta-2-adrenoreceptor Agonist
|
Beximco Pharmaceuticals Ltd.
|
Bangladesh
|
CLIDP Conversion
|
25 August 2022
|
04 December 2025
|
| View |
|
DRP-10801-06
|
Sodium bicarbonate
|
Bicardone
|
84 mg/mL (8.4% w/v)
|
Solution for Injection (I.V. Infusion)
|
Electrolyte Replenisher/Systemic Alkalinising Agent
|
BCWorld Pharm. Co., Ltd
|
Korea
|
CLIDP Conversion
|
25 August 2022
|
21 December 2026
|
| View |
|
DRP-11154-13
|
Nicardipine Hydrochloride
|
Execard
|
1mg/mL (10mg/10mL)
|
Solution for Injection (IV Infusion)
|
Calcium Channel Blocker (Dihydropyridine Derivative)
|
Makcur Laboratories Limited
|
India
|
CLIDP Conversion
|
25 August 2022
|
11 February 2027
|
| View |
|
DRP-11847-02
|
Sitagliptin (as phosphate monohydrate) + Metformin Hydrochloride
|
Philsitz-M
|
50 mg/ 1 g
|
Film-Coated Tablet
|
Combination of Oral Blood Glucose Lowering Drugs
|
Fredun Pharmaceuticals Limited
|
India
|
CLIDP Conversion
|
25 August 2022
|
10 May 2027
|
| View |
|
DRP-4295-03
|
Atorvastatin (as Calcium Trihydrate)
|
Florvast 80
|
80 mg
|
Film-Coated Tablet
|
HMG CoA Reductase Inhibitor
|
Stallion Laboratories Pvt. Ltd.
|
India
|
Renewal
|
25 August 2022
|
13 March 2028
|
| View |
|
DR-XY19288-B
|
Chloramphenicol
|
Sustachlor
|
500 mg
|
Capsule
|
Antibacterial (Amphenicol)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Renewal
|
25 August 2022
|
10 October 2027
|
| View |
DR-XY33322_PI_01.pdf
|
DR-XY33322
|
Morphine Sulfate
|
None
|
10mg/mL
|
Solution for Injection (I.M./I.V./S.C.)
|
Opioid Analgesic
|
Siegfried Hameln GmbH
|
Germany
|
-
|
21 May 2022
|
18 May 2027
|
| View |
|
DRP-12391-01
|
Clopidogrel (as bisulfate)
|
MUGREL
|
75 mg
|
Film-Coated Tablet
|
Antithrombotic (Antiplatelet)
|
J. Duncan Healthcare Pvt. Ltd.
|
India
|
CLIDP Conversion
|
22 August 2022
|
13 July 2027
|
| View |
|
DRP-1977-03
|
Omeprazole
|
Omera
|
40 mg
|
Capsule
|
-
|
Biopharma Laboratories Ltd.
|
Bangladesh
|
Renewal
|
22 June 2021
|
01 December 2024
|